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Background: Chronic pain is a growing global and economically costly problem leading the 
National Health Service (NHS) in the UK to actively search for novel strategies to improve 
health outcomes.  Some trials have shown a benefit when practitioners use a positive 
communication style, however, much of the available literature investigating the use of 
positive language to alter patient expectation utilises subjective reports from patients.  
Objectives: To demonstrate whether positive and negative communication before a high-
velocity low amplitude (HVLA) thrust spinal manipulation of the C7-T1 spine segments, and 
within an osteopathic consultation setting, increases and decreases (respectively) pain 
pressure thresholds (PPT) to form contextual placebo and nocebo effects. Study design: pre-
test, post-test randomised controlled design.  Methods: 35 asymptomatic participants were 
recruited and randomised into three separate condition arms using a repeated measures cross-
over design; negative communication (NegC), neutral communication (NeuC), or positive 
communication (PosC). Each condition included spinal manipulation (HVLA thrust) to the 
C7-T1 segments. PPTs were measured by an algometer over the spinous process of C7 pre 
and post each condition setting.  Results: There was a significant effect of language style on 
PPT for the three conditions. Post-hoc tests demonstrated that positive communication had a 
significant effect on PPT (i.e., placebo effect), but the negative communication demonstrated 
no significant effect (i.e., no nocebo). Conclusion: These results were discussed in the 
context of communication style used during an osteopathic clinical consultation to potentially 
improve health outcomes in NHS and other clinical settings (Clinical trial registry 
https://clinicaltrials.gov/ number: NCT03855254).  




Implications for Practice 
 
• Placebo effects may enhance HVLA thrust treatment. 
• Contextual factors may play an important role in osteopathic care.  
• Communication style may be implemented in NHS clinical settings. 




Chronic pain can be defined as pain which is not resolved during the normal period of tissue 
healing time (Fayaz, Croft, Langford, Donaldson, & Jones, 2016), with symptoms lasting a 
minimum of 3 months (Hildebrandt et al., 2004). During an episode of pain, quality of life 
can be dramatically reduced and the ability to carry out daily tasks is limited (Schmiemann et 
al., 2015). 
The epidemiological evidence suggests that the most common cause of disability 
worldwide is chronic pain (Vos et al., 2012). Chronic low back pain, for example, is now the 
most significant cause of years lived with disability in 86 countries worldwide (Brucki, 
2016). Fayaz et al. (Fayaz et al., 2016) found that in the United Kingdom alone, just under 28 
million people suffer from chronic pain and showed that there was a relation between age and 
incidence, where 62% of those over the age of 75 experience the condition. Recent 
estimations suggest that the economic burden of chronic pain in Europe is approximately 
€200 billion per year (Van Hecke, Torrance, & Smith, 2013). As a result of the cost and 
prevalence of this disability locally and worldwide, the National Health Service (NHS) have 




Currently, the treatment options for chronic pain is multidisciplinary in nature, with 
the main focus of treatment being educational, medical, and psychosocial (Finlay & Elander, 
2016).  However, although a multidimensional approach is advised, pharmacological 
prescription is still the most common treatment (Varrassi et al., 2010).  The guidelines for 
non-invasive treatments for acute, subacute, and chronic pain suggest that pharmaceuticals 
should be avoided and instead massage, acupuncture, superficial heat, or spinal manipulation 
should be preferred in the first instance (Qaseem, Wilt, McLean, & Forciea, 2017).   
Recent NICE guidelines (Bernstein, Malik, Carville, & Ward, 2017) suggest that an 
alternative to drug use when treating chronic pain is to use manual therapy as part of a 
broader package of treatments such as exercise therapy and psychological treatment.  One 
type of manual therapy which has received growing support from empirical evidence is called 
Osteopathic Manipulative Therapy (OMT), which utilises manipulation and mobilisation 
techniques.  There is, for example, some supportive evidence that thoracic manipulation has 
been shown to be effective when compared to a control for neck pain, whereas the results for 
cervical manipulation and mobilisation is more diverse and less clear as reported in a 
Cochrane review (Gross et al., 2015).   OMT has even been shown to reduce several co-
morbid pain-related psychological disorders such as anxiety, and to improve immediate 
mental health status (Edwards & Toutt, 2018).  Indeed, OMT (and manual therapy in general) 
have shown to have psychological benefits which have been supported by a systematic 
review (Saracutu, Rance, Davies, & Edwards, 2017).   
Psychological components can play an important role in pain perception and this has 
been previously modelled by researchers (Legrain, Iannetti, Plaghki, & Mouraux, 2011; 
Melzack, 1999) in a Neuromatrix model.  Melzack described pain as being entirely subjective 
and including somatosensory, limbic, and cognitive components. The Neuromatrix model 
suggests that a person's pain experience will be influenced by the combination of the sensory 
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input given, the individuals’ perceptions, previous experiences, and expectations. The link 
between the perception of pain, psychological expectation, and experience is also supported 
by recent research conducted which explores how contextual factors (CFs) influence pain 
perception (Testa & Rossettini, 2016).   
CFs have been found to be crucial for the management of musculoskeletal pain as 
identified in a recent review (Testa & Rossettini, 2016).  For example, they are recognised as 
having influence over every complex musculoskeletal intervention, but are currently 
considered as incidental rather than being used intentionally by clinicians (Paterson & 
Dieppe, 2005). CFs can produce a therapeutic effect through the same pain modulation 
pathways as activated by hands-on (e.g., manual therapy) and hands-off (e.g., pain 
neuroscience education) commonly practiced therapies (Bialosky et al., 2018; Bialosky, 
Bishop, Price, Robinson, & George, 2009; Bishop et al., 2015).  CFs can also serve as an 
additional tool to facilitate clinicians in relation to the complexities of pain management 
(Dieppe, Goldingay, & Greville-Harris, 2016).   
 More specific examples for the effectiveness of CFs have been demonstrated in cases 
of placebo and nocebo effects.  A placebo effect can be defined as an inert therapeutic 
procedure which produces a beneficial effect, but which cannot be attributed to the properties 
of the placebo itself but to the patients belief in the treatment’s effectiveness (Gottlieb, 2014). 
Or more simply, it can be defined as a form of contextual healing (Miller & Kaptchuk, 2008).  
A nocebo effect refers to the negative psychosocial context attributed to the patients beliefs 
about the therapeutic treatment’s effectiveness, and the negative effects this has on the 
patient’s brain or body (i.e., either a reduction of treatment effectiveness or actual harmful 




Placebo effects have been shown to have beneficial clinical effectiveness in situations 
when deliberately given to patients with fibromyalgia, as demonstrated in a recent meta-
analysis (Chen et al., 2017).  It has also been shown to have clinical effectiveness in the 
treatment of osteoarthritis, as demonstrated through a meta-analysis (Zhang, Robertson, 
Jones, Dieppe, & Doherty, 2008). Nocebo CFs, induced through negative suggestion, have 
been shown to increase pain across osteoporosis (Dieppe et al., 2016), rheumatoid arthritis 
(Chen et al., 2017) fibromyalgia (Goossens, Vlaeyen, Hidding, Kole-Snijders, & Evers, 2005) 
and headaches (Benedetti, Durando, & Vighetti, 2014).  CF effects have, in some cases, been 
found to be larger than the actual treatment effects.  This was demonstrated in a meta-analysis 
which found that in cases of spinal manual therapies for both acute and chronic pain; 
respectively 81% and 66% of the pain variance were ascribed to CFs (Menke, 2014).   
 To-date, the existing literature on CFs have focused on outcome measures such as; (1) 
patient satisfaction measures such as those identified in various systematic reviews (Hush, 
Cameron, & Mackey, 2011; Oliveira et al., 2012); (2) therapeutic alliance measures such as 
trust, rapport, and agreement between patient and the therapist (Pinto et al., 2012); (3) 
qualitative measures which focus on the influence of patient-therapist interactions, as 
identified in a systematic review (O'keeffe et al., 2016); (4) Visual Analogue Scales (VAS) 
for pain such as those identified in a meta-analysis for arthritis (Chen et al., 2017); (5) other 
subjective self-report measures (Goossens et al., 2005); (6) neurochemical enzymes such as 
cyclooxygenase in the saliva (Benedetti et al., 2014); (7) and other hormones such as cortisol 
and growth hormones (Benedetti et al., 2003).  
One outcome measure which has not been utilised frequently in relation to CF effects 
is the use of pain pressure thresholds (PPT).  The need to explore a comprehensive range of 
outcome measures in relation to CFs has been highlighted previously (Bialosky et al., 2009), 
and this includes pain thresholds, which would add to the growing body of evidence on CF 
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effects.  Pain thresholds are commonly used in OMT and other manual therapy research 
(Cathcart, McSweeney, Johnston, Young, & Edwards, 2019; McCoss, Johnston, Edwards, & 
Millward, 2017; Paungmali, O'Leary, Souvlis, & Vicenzino, 2003; Vicenzino, Paungmali, 
Buratowski, & Wright, 2001).  Pressure algometry was designed to record the smallest 
measurement of mechanical stimuli that can be perceived as pain (Fischer, 1987). There is 
some literature supporting the algometer as a reliable, valid, and easy method of measuring 
the hypoalgestic effects of manual therapy, with intraclass correlation coefficients found to be 
between 0.78 and 0.99 (Cathcart et al., 2019; Ylinen, Nykänen, Kautiainen, & Häkkinen, 
2007).   
Given the clinical significance of this test in manual therapy practice, it is perhaps 
surprising that not more studies relating to CFs have focused on PPT within OMT.  One 
study, however, did use PPTs in relation to a thermal pain sensitivity threshold with the use 
of a hand-held peltier-element-based stimulator.  They found that when using spinal 
manipulation therapy for the low back on asymptomatic participants (without pain), positive 
expectation CF lowered thermal pain sensitivity (thus increased thermal pain threshold), and 
negative expectation CF increased pain sensitivity (thus decreased thermal pain threshold) 
(Bialosky, Bishop, Robinson, Barabas, & George, 2008).  The present study expands on this 
work by focusing on a different type of pressure threshold, that being algometry induced PPT 
instead of a thermal threshold, and also with an asymptomatic population.  The key difference 
between this present study and that of Bialosky et al. is that in this present study we will 
explore the use of  a high velocity low amplitude (HVLA) thrust of the cervicothoracic 
junction (C7-T1) instead of the spinal manipulative therapy (SMT) which Bialosky used.   
This study is therefore unique as it investigates the impact of CF in an OMT setting 
with pain pressure thresholds (PPTs) and with the use of the HVLA thrust.  Though there are 
many potential OMT techniques, the HVLA thrust is a particularly advantageous method to 
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decrease chronic spinal pain, which has been seen to increase pain pressure threshold (PPT) 
both locally and distally (Coronado et al., 2012), particularly over the zygapophyseal joints 
(Fernández-De-Las-Peñas, Alonso-Blanco, Cleland, Rodríguez-Blanco, & Alburquerque-
Sendín, 2008) and spinous process (de Camargo et al., 2011).  
Therefore, the aim of this present study is to explore how CFs impact on PPT after a 
HVLA thrust.  Firstly, as the HVLA thrust has previously shown to increase PPT in a similar 
area (de Camargo et al., 2011) then it is (1) hypothesised that the HVLA thrust over the C7-
T1 spinal segments will lead to a significant interaction effect between time (pre and post 
intervention) and condition.  As a secondary hypothesis, it is also hypothesised that (2) there 
will be a significant increase in PPT overall (significant main effect of time; pre and post 
intervention). However, as studies have shown that negative communication have led to a 
significant reduction in thermal pain threshold (Bialosky et al., 2008) then it is (3) 
hypothesised that PPT will be significantly lower for the NegC condition when compared to 
the NeuC condition (i.e., nocebo effect). Finally, as positive communication has been shown 
to improve health outcomes (Little et al., 2001) and reduce pain activity in the brain (Keltner 
et al., 2006), as well as increase thermal thresholds (Bialosky et al., 2008); it is (4) thus 
hypothesised that PPT will be significantly greater in the PosC condition when compared to 




This was a three arm repeated measures crossover randomised controlled trial. The crossover 
design has the advantage of removing any individual differences in the population across the 
conditions as the same individuals are used for each condition.  The chances of obtaining a 
type 2 error can be reduced as a repeated crossover design has greater power than a between 
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groups design (Sibbald & Roland, 1998).  The CONSORT statement (Consolidated Standards 
of Reporting Trials) (Moher et al., 2010; Schulz, Altman, & Moher, 2010) was used for the 
reporting of this study.  
 
Participants 
Thirty-five asymptomatic (22 Female, 13 Male) first- and second-year undergraduate 
students participated in this study and were recruited via posters which were placed in the 
student communal areas. The inclusion criteria for this study included participants being aged 
between 18-45, having good comprehension of English to acquire valid informed consent, 
good or corrected to good vision, and having no present symptoms of pain. Participants were 
excluded if they had any existing or previous persistent pain (lasting for more than three 
months) or whiplash to the cervical spine (Csp) in the last year, were taking any analgesic or 
anti-inflammatory medication, or had hypermobility of the C7-T1 segments.  Relevant health 
information was obtained via a medical history questionnaire completed by participants 
before involvement in the study. The selected participants (once consent was taken) were 
then randomly assigned into a sequence of study conditions through the use of a computer 
research randomiser (see randomisation section).  All of the participants participated in the 
three condition arms (see CONSORT diagram in Figure 1).  These included a neutral 
communication condition (NeuC), a positive communication condition (PosC) and negative 
communication condition (NegC).  
 
---------------------------------------Figure 1 Here--------------------------------- 
 
Participant crossover randomisation 
9 
 
There were three condition arms and with six possible sequence combinations in this 
crossover randomisation design; [1, 2, 3]; [1, 3, 2]; [2, 1, 3]; [2, 3, 1]; [3, 1, 2]; [3, 2, 1].  In 
order to remove order effects, a computer-generated randomiser (Urbaniak & Plous, 2013) 
was then used to allocate the participants into one of the six condition sequences. This was 
conducted by researcher 3 (who was separate from the intervention and measurement stages 
of the actual experiment). A one-week washout period was employed between study 
conditions to prevent any within conditions intervention contamination.  The allocation 
assignment was held by the experimenters (researcher 2 and 3) and not revealed to the 
participants at any time. The participants were simply asked (by researcher 3) to attend three 
sessions on different dates and without knowing what their random allocation sequence was. 
Once allocated, the study was conducted over three weeks (January – February 2018) with 




Ethics were approved through the University Research Ethics Council (REC) which included 
participant consent, right to withdraw and a full debriefing at the end of the study.   
 
Blinding 
Researcher 1 (R1) conducted the measurements only, whilst Researcher 2 (R2) conduced the 
intervention only.  Researcher 3 (R3) randomised the participants into the sequence 
allocations and was not part of the intervention delivery or measurement stages.  Sequence 
allocation was only revealed to R2.  R1 left the laboratory during the intervention phase and 
was thus blind to the type of intervention given.  R2 left the laboratory during the 
measurement phase and was thus blind to the measurements taken.  Of course, despite the 
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researcher blinding, it is acknowledged that participants may have inferred elements of the 
study design (though these details were not given to them) given the repeated nature of it.  




Primary outcome measure 
Pain pressure thresholds (PPT). Pain pressure thresholds were measured obtained using a 
handheld Wagner FDX digital force gauge manufacturer calibrated algometer. The algometer 
had a rubber tip of 1cm and pressure was applied at a rate of 10 newtons/second.  
Pressure algometry is designed to record the smallest measurement of mechanical stimuli that 
can be perceived as pain (Fischer, 1987; Kinser, Sands, & Stone, 2009). Pressure algometry 
is frequently utilised to quantify whether there are any alterations in the participants’ pain 
perception following a treatment intervention (McCoss et al., 2017). There is some literature 
supporting the algometer as a reliable, valid, and an easy method of measuring the 
hypoalgestic effects of manual therapy (ICC = 0.78-0.99) (Antonaci, 1998; Cathcart et al., 
2019; Ylinen et al., 2007). Another paper have also reported good inter-examiner reliability 
(ICC = 0.75) and excellent intra-examiner reliability (ICC = 0.84)(Antonaci, 1998) . 
 
Procedure 
First the inclusion and exclusion criteria were applied to the participant selection (see 
participants section) and the selected participants were then randomised into one of the six 
condition sequences (see randomisation section).  Participants participated in all three study 
conditions based on the determined randomised sequence they were allocated to.  This 
included a one-week washout period between the conditions to reduce cross-condition 
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contamination effects. The study was conducted in a quiet research laboratory room with no 
clock. In all conditions the algometer was applied slowly to the allocated area at a steady rate 
of 10 (newtons per second) Ns-1. The participants were instructed to say ‘stop’ when they felt 
that pain was immediately uncomfortable, which is a subjective response. This was instructed 
as follows; ‘Please respond with the word stop when you feel the pain is immediately 
uncomfortable’. The study conditions were as follows: 
 
Neutral communication (NeuC).  
Baseline outcome readings of PPT over the C7 spinous process and demographic data (in the 
case that this was the first condition they participated in) were initially assessed by R1. R1 
then left the room whilst R2 entered and then told the participant: “I am going to carry out a 
spinal manipulation to an area at the bottom of your neck. There is limited evidence 
supporting the use of this technique, but it could reduce pain in this area.”  R2 then carried 
out a seated HVLA thrust manipulation to the C7-T1 segments (see Figure 2). R2 then 
assessed the mobility at the segment but made no comment to the participant. After this, R2 
left the room to be replaced by R1 who recorded the post intervention PPT measure. 
 
Positive communication (PosC).   
A baseline outcome readings of PPT over the C7 spinous process and demographic data (in 
the case that this was the first condition they participated in) were initially assessed by R1. 
R1 then left the room whilst R2 entered and then told the participant: “I am going to carry out 
a spinal manipulation to an area at the bottom of your neck. There is a lot of evidence 
supporting the use of this technique, it will reduce pain in this area.” R2 then carried out a 
seated HVLA thrust manipulation to the C7-T1 segments. R2 then assessed the mobility at 
the segment and explained to the participant that the tissue quality in the area had improved.  
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After this, R2 left the room to be replaced by R1 who recorded the post intervention PPT 
measure. 
 
Negative Communication (NegC).  
A baseline outcome readings of PPT over the C7 spinous process and demographic data (in 
the case that this was the first condition they participated in) were initially assessed by R1. 
R1 then left the room whilst R2 entered and then told the participant: “I am going to carry out 
a spinal manipulation to an area at the bottom of your neck. There is no evidence supporting 
the use of this technique to reduce pain in the area, so I am expecting no change”. R2 then 
carried out a seated HVLA thrust manipulation to the C7-T1 segments. R2 then assessed the 
mobility at the segment and explained to the participant that the tissue quality had not 
improved. After this, R2 left the room to be replaced by R1 who recorded the post 
intervention PPT measure. 
 
Application of the algometer and responses 
 
---------------------------------------Figure 2 Here--------------------------------- 
 
Site Location and Justification 
Though this study was concerned with context effects, a genuine (unbiased by context)  
treatment effect was sought for the neutral condition.  This was sought to identify whether the 
context effects in the positive and negative conditions increased or decreased this genuine 
effect through comparison with the neutral condition.  The site chosen to measure PPT was 
on the skin over the spinous process of C7. This site was located by passively assessing the 
participants cervical spine through flexion and extension.  It is identified as extension of the 
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C6 spinous process moves anteriorly and the C7 spinous process does not move (Shin, Yoon, 
& Yoon, 2011). Shin et al. (Shin et al., 2011) have suggested the flexion and extension 
method of locating the C6 and C7 vertebrae is the most accurate method.   
The site location of the C7 spinous process was chosen for PPT measurement as 
previous research has demonstrated that the application of a HVLA thrust manipulation to the 
C5-6 joint increases PPT over the C5 spinous process (de Camargo et al., 2011) and the 
zygapophyseal joints (Fernández-De-Las-Peñas, Pérez-De-Heredia, Brea-Rivero, & 
Miangolarra-Page, 2007). However, as the spinal manipulation aimed for cavitation of the 
C7-T1 zygapophyseal joints, like in other studies (de Camargo et al., 2011), PPT was 
therefore measured at the spinous process of the superior vertebrae (C7) in this study.  
 
Power calculation 
A G*Power 3.1 calculation (Faul, Erdfelder, Lang, & Buchner, 2007) gives an ideal sample 
size of 35, for a repeated measures ANOVA, where the effect size was set to an a priori 
moderate effect size of d = 0.5 ( 2pη  = 0.06), alpha at 0.05 and power at 0.91, according to 
Dattalo’s text book on determining sample size using G*Power (Dattalo, 2008). In this study, 
35 participants were recruited which had a power of 0.9 with only a 10% probability of 
making a type 2 error. 
 
Statistical analysis 
IBM’s SPSS software version 23 was used to conduct the data analysis. A logarithmic 
transform (log 10) was conducted to correct for positive skewed distributions.  A Shapiro-
Wilk test was then used to test the goodness of fit which confirmed that the data was sampled 
                                                          




from a normally distribution and thus the model was parametrically valid (p > 0.05).  This, 
therefore, justifies the use of parametric tests. Correcting non-normality through 
transformation does not affect the statistical relationship between variables (Field, 2009).   A 
general linear model consisting of a two (baseline / after intervention) by three (NeuC / PosC 
/ NegC) repeated measures analysis of variance (ANOVA) was conducted with PPT as the 
dependent measure. All participants (35) were included in the analysis. Outliers were 
assessed through visual boxplots, but no data were identified as extreme and no data were 





The demographics of the participants were are described in Table 1. There were 22 females 
and 13 males.  
 
---------------------------------------Table 1 Here--------------------------------- 
 
Descriptive statistics 
As can be seen in Table 1 and Figure 3 (for a bar chart representation of the differences), 
there was a post-condition increase in PTT for all study conditions. PosC demonstrated the 
greatest post-condition increase in PPT.   
 
---------------------------------------Table 2 Here--------------------------------- 





The assumptions of the parametric test were met (see statistical analysis section) as the data 
were normally distributed. See Table 3 for the inferential statistics. The main effect for 
condition (NeuC, NegC, and PosC) was significant and with a medium effect size.  The main 
effect for time (pre-post) was also significant with a large effect size.  Crucially, the 
interaction between time and condition was also significant. Bonferroni pairwise comparison 
was then used which indicated that the difference between NegC and NeuC was not 
significant (mean difference = 0.08, SE = 0.15, p = 0.59, CI = -0.22 to 0.38); the difference 
between NegC and PosC was significant (mean difference = -0.39, SE = 0.17, p < 0.01, CI = 
-0.74 to -0.41); the difference between NeuC and PosC was also significant (mean difference 
= - 0.47, SE = 0.18, p < 0.01, CI = -0.82 to -0.11).  The hypothesised assumptions for 
hypothesis 1, 2, 4 but not 3 were therefore met.   
 




The present study sought to investigate whether contextual effects would arise in the case of a 
HVLA thrust technique of the C7-T1 spinal segments. It was hypothesised that (1) there 
would be a significant interaction effect between time (pre and post intervention) and 
condition.  The second hypothesis (2) predicted that there would be a significant increase in 
PPT for all three conditions (significant main effect of time; pre and post intervention). It was 
also hypothesised that (3) PPT will be significantly lower for the NegC condition when 
compared to the NeuC condition (i.e., nocebo effect).  Finally (4), it was hypothesised that 




 The findings showed that for the primary hypothesis of an interaction between time 
and condition was observed and the null hypothesis can be rejected (significant interaction 
effect).  For the second hypothesis the null hypothesis can be rejected, thus all conditions 
significantly increased after the HVLA technique (a significant main effect of time; pre and 
post).  However, for the third hypothesis the null hypothesis cannot be rejected, thus there 
was no significant decrease in PPT in the NegC.  For the fourth hypothesis, the null 
hypothesis can be rejected, and it was found that the PosC PPT was significantly greater 
when compared to the NeuC condition.  
These findings are interesting and add to the growing body of evidence which 
demonstrate CFs can enhance treatment effects. These include specific studies which have 
shown the effectiveness of placebo (positive) CFs such as in cases for the treatment of 
fibromyalgia, as demonstrated in a recent meta-analysis (Chen et al., 2017) and in a meta-
analysis for the treatment of osteoarthritis (Zhang et al., 2008).   
There were, however, some differences in the present results and those found in other 
stuides.  For example, resarchers such as Bialosky (Bialosky et al., 2008) found that positive 
CFs (communication style; placebo effect) increased thermal pain thresholds which is 
consistent with the present findings, but they also found that negative CFs (communication 
style; nocebo effect) decreased thermal pain thresholds which is inconsistent with the present 
study findings. Similar findings have been demonstrated in other research such as that of 
Little et al. (Little et al., 2001) who found that a positive approach (positive CF) led to 
increasesed satfication, incresed feelings of enabledness, and reduced number of referals, but 
also found that negative approaches (negative CF) led to greater symptom burden.   
Nocebo CFs have been found in many other studies, for example, in the worsening 
effects of pain in cases of negative communication in areas of osteoporosis (Dieppe et al., 
2016), rheumatoid arthritis (Chen et al., 2017) fibromyalgia (Goossens et al., 2005) and 
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headaches (Benedetti et al., 2014).  The fact that nocebo effects were not found in the present 
study maybe due to the measurement type used (e.g., PPTs as opposed to VAS and other 
subjective measures) or perhaps that the participant sample used in this study were 
asymptomatic rather than a clinical population.   
One practical applications for this modulated patient perception of pain and treatment 
effectiveness could be to apply this as a novel health care protocol for clinical practice and 
this includes the NHS.  The conscious use of communication styles could be reinforced to 
improve healing times and health outcomes (Bialosky et al., 2008).  A review by Testa and 
Rossettini (Testa & Rossettini, 2016) suggested that placebo enhancement should be sought 
in clinical practice whilst nocebo should be avoided.  However, further clinical trials would 
first be needed to be conducted on a pain population and which would also explore potential 
adverse effects (for example, to explore what the effects would be if the placebo is later 
removed, which may alter the treatments genuine effectiveness). 
There are of course ethical considerations when trying to enhance the treatment 
outcomes through the use of CFs which lead to placebo effects.  However, amongst 
healthcare providers, the adoption of placebo strategies seem to be commonplace (Fässler, 
Meissner, Schneider, & Linde, 2010).  Examples of professionals who condone the use of 
CFs for musculoskeletal pain specifically include; orthopaedic surgeons, rheumatology 
physicians and nurses, who all feel that placebo effects are real and permissible within the 
ethical boundaries of health care (Baldwin, Wartolowska, & Carr, 2016; Berthelot, Maugars, 
Abgrall, & Prost, 2001; Wartolowska, Beard, & Carr, 2014).  Also, it is not just professional 
staff who feel this practice is permissible. Patients with chronic musculoskeletal pain and 
rheumatologic complaints also feel that CF effects are an acceptable adjunct treatment 
alongside actual treatment. (Berthelot et al., 2001; Hughes et al., 2017; Kisaalita, Staud, 
Hurley, & Robinson, 2014). 
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Some scientific and medical communities have focused on the transparent disclosure 
of placebo treatments (Alfano, 2015; Blease, Colloca, & Kaptchuk, 2016; Miller & Colloca, 
2009, 2011), whereby, for example, a sham treatment could be given with prior consent 
(Bishop et al., 2017).  The general consensus seems to be that in order to maintain best 
evidence-based therapy then this informing of the participants and without deception should 
be sought (Annoni & Miller, 2016; Blease et al., 2016; Charlesworth et al., 2017).  
Surprisingly, despite the common belief that disclosing the placebo intervention reduces its 
efficacy, this has not been found to be true as the placebo effect has still been found in open 
label trials with full condition disclosure given to patients (Bialosky & Robinson, 2017; 
Carvalho et al., 2016).  So, the consensus so far seems to be to establish ethical mindful 
manipulation of CF effects where there is disclose, which may represent a useful opportunity 
to enrich well-established therapies (Miller & Colloca, 2009).  This would allow for the 
implementation of CF knowledge in daily therapeutic practice rather than labelling CFs as 
unknown confounding factors (Linde, Fässler, & Meissner, 2011; Rossettini & Testa, 2017).  
However, much work still needs to be carried out on CFs as there has been quite a lot 
of work done to understand how CFs affect pain (Carlino & Benedetti, 2016; Carlino, 
Frisaldi, & Benedetti, 2014) but there is still much that in not know in relation to the impact 
of CFs on different populations.  For example, little is known about the impact of CF effects 
on young and old sufferers of musculoskeletal pain (Simmons et al., 2014), in chronic and 
acute conditions (Müller et al., 2016) and between different pain mechanisms such as 
nociceptive, neuropathic, and central sensitisation (Nijs et al., 2015).  It is suggested that it is 
of paramount importance to understand the psychological, psychophysiological, 
neuroendocrine and genetic elements that predict the responsiveness of certain CFs (Enck, 
Bingel, Schedlowski, & Rief, 2013), so perhaps this is where future studies should focus in 
relation to CF effects.   
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One potential limitation is that this was a repeated measures deign and that this can be 
subject to order effects.  However, this was mitigated largely due to the fact that the 
sequences were counterbalanced thus balancing any bias of order effects. Of course, the 
advantage of using a repeated study design is that it removes any individual difference bias 
and increases the statistical power when compared to a between design. A second potential 
limitation of this study is that is used a asymptomatic population and not a pain population, 
so generalisability is always questionable. As the intention was to test the proof-of-concept 
first for this specific HVLA thrust context, before testing on a chronic pain population (for 
ethical reasons), this was deemed an appropriate first study step. This study was motivated in 
part to compare with study results of Bialosky et al. (Bialosky et al., 2008), who also used 
asymptomatic patients.  The justification of use and generalisability of asymptomatic patients 
has been made by Bialosky et al. (Bialosky et al., 2008) in this context as a valid means to 
assess placebo and nocebo effects.  They stated that participants experiencing clinical pain 
have a greater desire for pain relief with greater expectations for the benefits of treatment, so 
studies would likely find an increase in placebo effect with a pain population. The use of 
asymptomatic participants, therefore, may have limitations but it does allow for comparisons 
to be made with other relevant work such as that from Bialosky.  
The fact that the CF effects seemed to have a greater impact than the HVLA thrust 
condition could be attributed to the fact that the patients were asymptomatic.  Hence, there is 
a clear need to explore a population in pain. More studies are also needed in the area like this 
and Bialosky et al. (Bialosky et al., 2008) to effectively compare how CF effects modulate 
specific outcomes of techniques for different bodily areas for both pain and asymptomatic 
populations.  
 In conclusion, the present study findings provide further evidence for CF effects in 
relation to a HVLA thrust technique in manual therapy. Given this and the fact that UK 
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Health Boards are actively looking for novel methods to reduce costs and increase the 
efficacy of treatment (Magalhães et al., 2015), then further investigation into CF effects are 
much needed, as this is perhaps one effective way of increasing efficacy at low cost. 
Exploring CFs in the context of OMT seems to be particularly useful given its focus on 
producing a patient centred and personalised treatment plan which could easily incorporate 
CFs into the plan.  However, much further research is needed to support a more conscientious 
therapeutic approach to the use of CFs in health professional practices such as physiotherapy, 
chiropractic, osteopathathy, nursing, occupational therapy, rheumatology, and orthopaedic 
practice, who all work with musculoskeletal pain patients.  These may include; (1) defining 
how CFs work from a neurophysiological perspective; (2) to define the clinical relevance in 
pain management; (3) to consider the use of CFs within established ethical boundaries; (4) 
and to suggest how to utilise this wealth of knowledge when utilising CFs in clinical practice.  
Perhaps once these are further understood, the conscientious use of CF effects will become 
more prevalent in day to day healthcare practice, and this is becoming an exciting area for 
OMT research.  
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Figure 3.  
Bar chart showing the average PPT scores for each condition with error bars representing 1 




Note: * indicates a significant difference between pre and post condition at p<0.05.  NegC = 






























Demographic data, 16 males and 19 females (Total N = 35) 
 
Measurement           Mean       SD                           
                                 
       
 
Age  (Years)                21.50              4.26       
Height (CM)                175.63            9.65       
Weight (KG)               70.90              10.64       
BMI                             22.97              2.33       
 
SD=Standard Deviation; Age=years; Weight=kilograms;  







































Descriptive statistics of the PPT measure for each condition pre and post intervention.  
 
Condition                    Pre-Mean (SD)         Post-Mean (SD)                
                                                                                                  
 
NegC 1.28 (0.47) 1.41 (0.66)  
NeuC 1.19 (0.59) 1.34 (0.58)  
PosC 1.39 (0.64) 2.07 (0.97)  
 
NegC = Negative communication condition; NeuC = Neutral communication condition;  































Inferential statistics of the PPT measure for each condition pre and post intervention. 
 
Condition                    F (df)            Sum of Squares         Mean Square              p                   η𝑝𝑝2  




4.61 (2)         8.76 4.38 =0.013 0.12 
Time (main 
effect) 




26.94 (2)        3.27 1.64 <0.001 0.44 
   
 
NegC = Negative communication condition; NeuC = Neutral communication condition;  
PosC = Positive communication condition 
 
 
 
 
 
 
 
